Cécile SCHIFFER-MANNIOUI

Person

Villiers sur Marne, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen rece...
- Patent number 11,987,639
- Issue date May 21, 2024
- CELLECTIS
- Cècile Schiffer-Mannioui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Universal chimeric antigen receptor T cells specific for CD22
- Patent number 11,690,873
- Issue date Jul 4, 2023
- Cellectis SA
- Cecile Schiffer-Mannioui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for engineering highly active T cell for immunotherapy
- Patent number 11,311,575
- Issue date Apr 26, 2022
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering allogeneic and highly active t cell for imm...
- Patent number 11,304,975
- Issue date Apr 19, 2022
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD19 specific chimeric antigen receptor and uses thereof
- Patent number 11,077,144
- Issue date Aug 3, 2021
- Cellectis
- Roman Galetto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD19 specific chimeric antigen receptor and uses thereof
- Patent number 11,007,224
- Issue date May 18, 2021
- Cellectis
- Roman Galetto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD19 specific chimeric antigen receptor and uses thereof
- Patent number 10,874,693
- Issue date Dec 29, 2020
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen rece...
- Patent number 10,759,868
- Issue date Sep 1, 2020
- Cellectis
- Cècile Schiffer-Mannioui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-GD3 specific chimeric antigen receptors for cancer immunotherapy
- Patent number 10,752,670
- Issue date Aug 25, 2020
- Cellectis
- Julianne Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ROR1 (NTRKR1) specific chimeric antigen receptors for cancer immuno...
- Patent number 10,752,684
- Issue date Aug 25, 2020
- Cellectis
- Cècile Schiffer-Mannioui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ROR1 specific multi-chain chimeric antigen receptor
- Patent number 10,544,201
- Issue date Jan 28, 2020
- Cellectis
- Cècile Schiffer-Mannioui
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...
- Publication number 20230201260
- Publication date Jun 29, 2023
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
New mesothelin specific chimeric antigen receptors (CAR) for solid...
- Publication number 20230068949
- Publication date Mar 2, 2023
- CELLECTIS
- Cecile SCHIFFER-MANNIOUI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY
- Publication number 20230056268
- Publication date Feb 23, 2023
- CELLECTIS
- Roman GALETTO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...
- Publication number 20230050345
- Publication date Feb 16, 2023
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW UNIVERSAL CHIMERIC ANTIGEN RECEPTOR T CELLS SPECIFIC FOR CD22
- Publication number 20210100839
- Publication date Apr 8, 2021
- CELLECTIS S.A.
- Cecile Schiffer-Mannioui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
- Publication number 20210060080
- Publication date Mar 4, 2021
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
- Publication number 20210060079
- Publication date Mar 4, 2021
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
- Publication number 20210000869
- Publication date Jan 7, 2021
- CELLECTIS
- Roman GALETTO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECE...
- Publication number 20200407461
- Publication date Dec 31, 2020
- CELLECTIS
- Cècile SCHIFFER-MANNIOUI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
- Publication number 20190209616
- Publication date Jul 11, 2019
- CELLECTIS
- Roman GALETTO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-GD3 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY
- Publication number 20180291079
- Publication date Oct 11, 2018
- CELLECTIS
- Julianne SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ROR1 (NTRKR1) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNO...
- Publication number 20170283497
- Publication date Oct 5, 2017
- CELLECTIS
- Cècile SCHIFFER-MANNIOUI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EGFRvIII Specific Chimeric Antigen Receptor For Cancer Immunotherapy
- Publication number 20170275366
- Publication date Sep 28, 2017
- Pfizer Inc.
- Cecile SCHIFFER-MANNIOUI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECE...
- Publication number 20170275374
- Publication date Sep 28, 2017
- CELLECTIS
- Cècile SCHIFFER-MANNIOUI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ROR1 SPECIFIC MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR
- Publication number 20170226183
- Publication date Aug 10, 2017
- CELLECTIS
- Cècile SCHIFFER-MANNIOUI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
- Publication number 20160145337
- Publication date May 26, 2016
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...
- Publication number 20160120905
- Publication date May 5, 2016
- CELLECTIS
- Roman GALETTO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY
- Publication number 20160120906
- Publication date May 5, 2016
- CELLECTIS
- Roman GALETTO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Cécile SCHIFFER-MANNIOUI

Person

Patents Grantslast 30 patents

Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen rece...

Universal chimeric antigen receptor T cells specific for CD22

Methods for engineering highly active T cell for immunotherapy

Methods for engineering allogeneic and highly active t cell for imm...

CD19 specific chimeric antigen receptor and uses thereof

CD19 specific chimeric antigen receptor and uses thereof

CD19 specific chimeric antigen receptor and uses thereof

Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen rece...

Anti-GD3 specific chimeric antigen receptors for cancer immunotherapy

ROR1 (NTRKR1) specific chimeric antigen receptors for cancer immuno...

ROR1 specific multi-chain chimeric antigen receptor

Patents Applicationslast 30 patents

METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...

New mesothelin specific chimeric antigen receptors (CAR) for solid...

METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY

METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...

NEW UNIVERSAL CHIMERIC ANTIGEN RECEPTOR T CELLS SPECIFIC FOR CD22

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECE...

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

ANTI-GD3 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY

ROR1 (NTRKR1) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNO...

EGFRvIII Specific Chimeric Antigen Receptor For Cancer Immunotherapy

TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECE...

ROR1 SPECIFIC MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...

METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY